-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V8qhv0aT+gvVeGHrE7qsapXLU39p7I66ttbvVmlS0v1kaqQWshBQyUeriVtoHyPI cjiuH/QW98Tc5c3Pa4kwNg== 0001021408-03-002919.txt : 20030214 0001021408-03-002919.hdr.sgml : 20030214 20030214145218 ACCESSION NUMBER: 0001021408-03-002919 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SALIX PHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001009356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943267443 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-53269 FILM NUMBER: 03566637 BUSINESS ADDRESS: STREET 1: 8540 COLONNADE CENTER DR STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 9198621000 MAIL ADDRESS: STREET 1: 8540 COLONNADE CENTER DR STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: SALIX HOLDINGS LTD DATE OF NAME CHANGE: 19970807 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON LORIN K CENTRAL INDEX KEY: 0001053878 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 3600 W BAYSHORE ROAD SUITE 205 CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 6508561550 MAIL ADDRESS: STREET 1: 3600 W BAYSHORE ROAD SUITE 205 CITY: PALO ALTO STATE: CA ZIP: 94303 SC 13G/A 1 dsc13ga.htm LORIN K. JOHNSON Lorin K. Johnson

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934

Amendment No. 4

 

 

 

 

 

Salix Pharmaceuticals, Ltd.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

 

 

795435 10 06

                                (CUSIP Number)                                

 

 

December 31, 2002

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

 

x Rule 13d-1(c)

 

¨ Rule 13d-1(d)

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

CUSIP No. 795435 10 06

 

  1.


  

Name of Reporting Person

I.R.S. Identification No. of above person (entities only).

 

Lorin K. Johnson

    

  2.

  

Check the Appropriate Box if a Member of a Group

(a)   ¨

(b)   ¨

Not Applicable

    

  3.


  

SEC Use Only

 

    

  4.


  

Citizenship or Place of Organization

 

United States

    

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

  

  5.    Sole Voting Power

 

        95,083

  6.    Shared Voting Power

 

        781,361         

  7.    Sole Dispositive Power

 

        95,083         

  8.    Shared Dispositive Power

 

        781,361        

  9.


  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

876,444

    

10.


  

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

 

¨

   

11.


  

Percent of Class Represented by Amount in Row (9)

 

4.1%

    

12.


  

Type of Reporting Person

 

IN

    

 

Page 2 of 6 Pages

 

Item 1(a)      Name of Issuer

 

Salix Pharmaceuticals, Ltd

 

Item 1(b)      Address of Issuer’s Principal Executive Offices

 

8540 Colonnade Center Drive, Suite 501, Raleigh, North Carolina 27615

 

Item 2(a)      Name of Person Filing

 

Lorin K. Johnson

 

Item   2(b)      Address of Principal Business Office, or, if None, Residence

 

3600 West Bayshore Road, Suite 205, Palo Alto, California 94303

 

Item 2(c)      Citizenship

 

United States

 

Item 2(d)      Title of Class of Securities

 

Common Stock

 

Item 2(e)      CUSIP Number

 

795435 10 06

 

Item   3.         If this Statement is filed pursuant to § 240.13d-1(b) or § 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)    ¨   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

(b)    ¨   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)

 

(c)    ¨   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d)    ¨   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

(e)    ¨   An investment advisor in accordance with § 240.13d-1(b)(1)(ii)(E);

 

(f)    ¨   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

 

 

Page 3 of 6 Pages

 

(g)    ¨   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

 

(h)    ¨   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i)     ¨   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the    Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

(j)     ¨   Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

 

x   NOT APPLICABLE

 

Item 4.    Ownership

 

  (a)       Amount beneficially owned:

 

At December 31, 2002 Mr. Johnson beneficially owned an aggregate of 876,444 shares of the Issuer’s common stock which includes: (i) 750,501 shares held by L. and L. Dantzker/Johnson Revocable Trust with respect to which Mr. Johnson is the co-trustee and a beneficiary; (ii) 30,860 shares held by Johnson Grandchildren’s Trust with respect to which Mr. Johnson’s wife is the co-trustee; and (iii) 2,083 shares issuable upon exercise of options that were exercisable within 60 days of December 31, 2002. With regard to the 781,361 shares held by the above trusts, Mr. Johnson disclaims beneficial ownership of such shares.

 

  (b)   Percent of class:

 

4.1%

 

  (c)   Number of shares as to which such person has:

 

  (i)   Sole power to vote or to direct the vote: 95,083
  (ii)   Shared power to vote or to direct the vote: 781,361
  (iii)   Sole power to dispose or to direct the disposition of: 95,083
  (iv)   Shared power to dispose or to direct the disposition of: 781,361

 

Item 5.      Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:    x

 

Page 4 of 6 Pages

 

Item 6.      Ownership of More than Five Percent on Behalf of Another Person

 

  Not   Applicable

 

Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

 

  Not   Applicable

 

Item 8.      Identification and Classification of Members of the Group

 

  Not   Applicable

 

Item 9.      Notice of Dissolution of Group

 

  Not   Applicable

 

Item 10.    Certification

 

  (a)   Not Applicable

 

  (b)   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 5 of 6 Pages

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

February 14, 2003

Date

/s/ Lorin K. Johnson

 

Page 6 of 6 Pages

-----END PRIVACY-ENHANCED MESSAGE-----